Jianxiong Jiang, Ph.D.
Affiliations: | 2004-2008 | Biological Sciences | Auburn University, Auburn, AL, United States |
| 2008-2014 | Pharmacology | Emory University School of Medicine, Atlanta, GA, United States | |
| 2015-2018 | College of Pharmacy | University of Cincinnati, Cincinnati, OH | |
| 2018- | College of Pharmacy | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Neuropharmacology, Epilepsy, GliomaWebsite:
https://jiang.lab.uthsc.eduGoogle:
"Jianxiong Jiang"Mean distance: 14.01 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Marie W. Wooten | grad student | 2004-2008 | Auburn University |
| Ray Dingledine | post-doc | 2008-2014 | Emory |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sluter MN, Li Q, Yasmen N, et al. (2023) The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders. Experimental Biology and Medicine (Maywood, N.J.). 15353702231179926 |
| Qiu J, Li Q, Li J, et al. (2023) Complementary roles of EP2 and EP4 receptors in malignant glioma. British Journal of Pharmacology |
| Sluter MN, Bhuniya R, Yuan X, et al. (2023) Novel, Brain-Permeable, Cross-Species Benzothiazole Inhibitors of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Dampen Neuroinflammation and . Acs Pharmacology & Translational Science. 6: 587-599 |
| Gu M, Yu Y, Xue M, et al. (2023) The discovery of cyclic γ-AApeptides as the promising ligands targeting EP2. Bioorganic & Medicinal Chemistry Letters. 87: 129255 |
| Chen Y, Nagib MM, Yasmen N, et al. (2023) Neuroinflammatory mediators in acquired epilepsy: an update. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.] |
| Yasmen N, Sluter MN, Li L, et al. (2023) Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective. Molecular Brain. 16: 14 |
| Hou R, Yu Y, Jiang J. (2022) Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling? Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 156: 113966 |
| Li L, Chen Y, Sluter MN, et al. (2022) Ablation of Siglec-E augments brain inflammation and ischemic injury. Journal of Neuroinflammation. 19: 191 |
| Hou R, Yu Y, Sluter MN, et al. (2022) Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma. Cell Reports. 39: 111000 |
| Zhang C, Sajith AM, Xu X, et al. (2022) Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation. Bioorganic & Medicinal Chemistry. 58: 116645 |